C
Centrum Medyczne EuroMedis | Szczecin, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Donanemab
AVP-786
LY3002813
LY3372689
Orforglipron
Deudextromethorphan Hydrobromide
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...
Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration includ...
Enrolling
Alzheimer Disease
Mental Disorders
Drug: Placebo
Drug: Donanemab
The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...
Not yet enrolling
Urinary Incontinence,Stress
Drug: Placebo
Drug: Orforglipron
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems